Deciphera Pharmaceuticals...

NASDAQ: DCPH · Real-Time Price · USD
25.59
0.02 (0.08%)
At close: Jun 10, 2024, 10:00 PM

DCPH Insider Trading

We track 756 insider transactions spanning 7 purchases and 221 sales, with a total transaction value of $352.85M. Recent activity shows 0 transactions in the last 90 days, indicating insider distribution among company executives and key stakeholders.

756 Transactions

Name Transaction Date Shares Price Value Type
Brightstar Associates LLC 10 % Owner
Apr 22, 2024 48,136 $0.01 $481.36 X-InTheMoney
Brightstar Associates LLC 10 % Owner
Apr 22, 2024 48,136 $0.01 $481.36 X-InTheMoney
Sherman Matthew L EVP & Chief Medical Officer
Feb 16, 2024 2,615 $15.62 $40,840.286 S-Sale
Kelly Thomas Patrick Chief Financial Officer
Feb 16, 2024 3,010 $15.62 $47,009.277 S-Sale
Pitman Jama SVP, Chief Development Officer
Feb 16, 2024 2,267 $15.62 $35,405.099 S-Sale
Martin Daniel C. Chief Commercial Officer
Feb 16, 2024 2,267 $15.62 $35,405.099 S-Sale

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access to all data and tools
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Realtime Options & Dark Pool Data
Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
Top Wallstreet Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.